The US Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

Remdesivir gets US FDA approval for hospitalized COVID-19 patients

The World Health Organization (WHO) has said that remdesivir has had little or no effect on coronavirus patients' length of hospital stay or chances of survival.

Remdesivir did not cut hospital stay or mortality in virus patients: WHO

trump-on-remdesivir

Trump On Remdesivir, News on Trump On Remdesivir, stories on Trump On Remdesivir, articles on Trump On Remdesivir, Trump On Remdesivir stories at Wion, Trump On Remdesivir news, Trump On Remdesivir latest news

trump on-remdesivir

Remdesivir gets US FDA approval for hospitalized COVID-19 patients

Remdesivir did not cut hospital stay or mortality in virus patients: WHO